Skip to main content
. 2018 Apr 24;9(31):21731–21743. doi: 10.18632/oncotarget.24932

Figure 6.

Figure 6

(AE) MRI monitoring of in vivo EPNs. (A, B, E) T2-weighted images. (C, D) T2*-weighted images. (A, C) Detection of MION-Rh labeled EPN cells. (B, D) Detection of unlabeled EPN cells. (E) Control without any EPN cell transplantation.